Literature DB >> 9802926

A limited lupus anti-spliceosomal response targets a cross-reactive, proline-rich motif.

M R Arbuckle1, A R Schilling, J B Harley, J A James.   

Abstract

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by the production of large amounts of characteristic autoantibodies. Anti-Sm and anti-nRNP (also known as anti-spliceosome) autoantibodies are among these. Previous epitope mapping of anti-spliceosomal antibodies has identified multiple antigenic determinants within this complex immune response. In this report we describe an SLE patient with a relatively simple, long-lasting anti-spliceosomal response. In the earliest serum sample tested the autoimmune response appeared restricted to the similar peptides PPPGMR(P,G)P of Sm B/B', PAPGMRPP of nRNP C, and PPPGMIPP of nRNP A. Unlike all the other tested lupus patients with anti-spliceosomal autoantibodies, in this patient these proline-rich epitopes remained the primary target for humoral autoimmunity in subsequent serum samples collected over many years. Absorption of anti-PAPGMRPP antibodies also removed binding to PPPGMR(P,G)P and PPPGMIPP. Isolated antibodies to PAPGMRPP were capable of binding Sm B/B', nRNP C and nRNP A by Western blot. For this particular SLE patient the autoimmune response observed against these three proteins is a single cross-reactive response against a similar proline-rich motif. Also, this patient has failed to undergo the B cell epitope spreading, typically observed in the naturally arising autoimmune response against the spliceosome in human lupus patients. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9802926     DOI: 10.1006/jaut.1998.0227

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  8 in total

1.  Elevated immunoglobulin G antibodies to the proline-rich amino-terminal region of Epstein-Barr virus nuclear antigen-2 in sera from patients with systemic connective tissue diseases and from a subgroup of Sjögren's syndrome patients with pulmonary involvements.

Authors:  M Yamazaki; R Kitamura; S Kusano; H Eda; S Sato; M Okawa-Takatsuji; S Aotsuka; K Yanagi
Journal:  Clin Exp Immunol       Date:  2005-03       Impact factor: 4.330

2.  Epitope mapping of the U1 small nuclear ribonucleoprotein particle in patients with systemic lupus erythematosus and mixed connective tissue disease.

Authors:  J A Somarelli; A Mesa; R Rodriguez; R Avellan; L Martinez; Y J Zang; E L Greidinger; R J Herrera
Journal:  Lupus       Date:  2011-03       Impact factor: 2.911

3.  Lupus-like autoantibody development in rabbits and mice after immunization with EBNA-1 fragments.

Authors:  Brian D Poole; Timothy Gross; Shannon Maier; John B Harley; Judith A James
Journal:  J Autoimmun       Date:  2008-10-11       Impact factor: 7.094

4.  Autoantibody signatures involving glycolysis and splicesome proteins precede a diagnosis of breast cancer among postmenopausal women.

Authors:  Jon J Ladd; Timothy Chao; Melissa M Johnson; Ji Qiu; Alice Chin; Rebecca Israel; Sharon J Pitteri; Jianning Mao; Mei Wu; Lynn M Amon; Martin McIntosh; Christopher Li; Ross Prentice; Nora Disis; Samir Hanash
Journal:  Cancer Res       Date:  2012-12-26       Impact factor: 12.701

5.  Early targets of nuclear RNP humoral autoimmunity in human systemic lupus erythematosus.

Authors:  Brian D Poole; Rebecca I Schneider; Joel M Guthridge; Cathy A Velte; Morris Reichlin; John B Harley; Judith A James
Journal:  Arthritis Rheum       Date:  2009-03

6.  Aberrant Epstein-Barr viral infection in systemic lupus erythematosus.

Authors:  Brian D Poole; Amanda K Templeton; Joel M Guthridge; Eric J Brown; John B Harley; Judith A James
Journal:  Autoimmun Rev       Date:  2009-01-22       Impact factor: 9.754

7.  Epstein Barr virus nuclear antigen 1 (EBNA-1) peptides recognized by adult multiple sclerosis patient sera induce neurologic symptoms in a murine model.

Authors:  Neelakshi R Jog; Micah T McClain; Latisha D Heinlen; Timothy Gross; Rheal Towner; Joel M Guthridge; Robert C Axtell; Gabriel Pardo; John B Harley; Judith A James
Journal:  J Autoimmun       Date:  2019-09-09       Impact factor: 14.511

8.  Epstein-Barr Functional Mimicry: Pathogenicity of Oncogenic Latent Membrane Protein-1 in Systemic Lupus Erythematosus and Autoimmunity.

Authors:  Melissa E Munroe; Jourdan R Anderson; Timothy F Gross; Laura L Stunz; Gail A Bishop; Judith A James
Journal:  Front Immunol       Date:  2021-02-03       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.